PF-05150122
PF-05150122 is a novel potent and selective human Nav1.7 channel blocker with the activity of inhibiting human pain signaling. PF-05150122 exhibited favorable biopharmacokinetic parameters in microdose studies, providing a basis for exploring its application in acute or chronic pain inhibition. The pharmacokinetic model of PF-05150122 predicted that at the corresponding oral dose, it could effectively reduce the 50% inhibitory concentration (IC50) of Nav1.7, demonstrating its inhibitory potential[1].
Product Specifications
CAS Number
[1235406-00-4]
UNSPSC
12352005
Target
Sodium Channel
Type
Reference compound
Related Pathways
Membrane Transporter/Ion Channel
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/pf-05150122.html
Smiles
N#CC1=CC(S(=O)(NC2=CSC=N2)=O)=CC=C1OC3=C(C4=CC=NN4C5CN(C5)CC)C=C(Cl)C=C3
Molecular Formula
C24H21ClN6O3S2
Molecular Weight
541.04
References & Citations
[1]Clinical Micro-Dose Studies to Explore the Human Pharmacokinetics of Four Selective Inhibitors of Human Nav1.7 Voltage-Dependent Sodium Channels
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
Phase 1
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
GDC-0449, SMO Inhibitor (2-Chloro-N- (4-chloro-3- (pyridine-2-yl) phenyl) -4- (methylsulfonyl) benzamide, HhAntag691) discontinued
GDC-0449, SMO Inhibitor (2-Chloro-N- (4-chloro-3- (pyridine-2-yl) phenyl) -4- (methylsulfonyl) benzamide, HhAntag691) discontinued
Rat Monoclonal TCP1 alpha Antibody (23c (CTA-123)) [mFluor Violet 450 SE]